A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Clinical trial NCT06797336 · RECRUITING
Trial details
- NCT number
- NCT06797336
- Sponsor
- PAQ Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2026-12-15
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.